G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $315,000 | -65.5% | 11,912 | -78.4% | 0.02% | -70.9% |
Q1 2019 | $914,000 | +25.2% | 55,038 | +44.4% | 0.06% | +17.0% |
Q4 2018 | $730,000 | +7.0% | 38,125 | +192.2% | 0.05% | +51.6% |
Q3 2018 | $682,000 | -32.4% | 13,047 | -43.8% | 0.03% | -24.4% |
Q2 2018 | $1,009,000 | +134.1% | 23,232 | +99.5% | 0.04% | +141.2% |
Q1 2018 | $431,000 | – | 11,645 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |